Jeffrey M. Dayno - Jul 22, 2021 Form 4 Insider Report for Harmony Biosciences Holdings, Inc. (HRMY)

Role: Chief Medical Officer
Signature: /s/ Christian Ulrich, Attorney-in-fact
Stock symbol: HRMY
Transactions as of: Jul 22, 2021
Transactions value $: -$1,089
Form type: 4
Date filed: 7/23/2021, 04:30 PM
Next filing: Aug 11, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HRMY	Common Stock	Options Exercise	$411	+50		$8.22^*	50	Jul 22, 2021	Direct
transaction	HRMY	Common Stock	Sale	-$1.5K	-50	-100%	$30.00	0	Jul 22, 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HRMY	Stock Option	Options Exercise	$0	-50	-0.05%	$0.00	103K	Jul 22, 2021	Common Stock	50	$8.22	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2	The stock option is currently vested with respect to 82,777 shares, and will vest with respect to the remainder of the shares in two equal annual installments beginning on October 13, 2021.